Keywords
Refractory cirrhotic ascites
Clinical efficacy
Submitted : 2024-09-02
Accepted : 2024-09-17
Published : 2024-10-02
Abstract
Objective: To analyze the efficacy of autologous bone marrow mesenchymal stem cell (BMSC) transplantation for the treatment of cirrhotic ascites (refractory). Methods: 64 patients with cirrhosis ascites (refractory) who were admitted to the hospital between May 2022 and April 2024 were selected and divided equally by random number table, the observation group was treated with BMSC autologous transplantation, and the reference group was treated with conventional medication, and the total effective rate, therapeutic indexes, liver and renal function indexes, and the change of urine volume were compared. Results: The total effective rate of the observation group was higher than that of the reference group (P < 0.05). Before treatment, there was no difference between the two groups in terms of therapeutic indexes such as depth of ascites, liver and kidney function indexes and 24-hour urine volume (P > 0.05). After treatment, the observation group’s ascites depth and other indicators were better than that of the reference group, liver and kidney function indicators were better than that of the reference group, and 24h urine volume was more than that of the reference group (P < 0.05). Conclusion: BMSC autotransplantation can improve the clinical efficacy of patients with cirrhosis ascites (refractory), accelerate the absorption of ascites, reduce the values of body mass and abdominal circumference, and protect the liver and kidney functions and increase the amount of urination.
References
Xie L, Chen H, Hao J, et al., 2023, Clinical Study on the Treatment of Refractory Ascites in Liver Cirrhosis with Spleen Deficiency and Water-Stopping Type by Applying Umbilical Cord with Soft Liver and Water-Relieving Formula Combined with Water-Expelling Formula. Journal of Liver Diseases of Chinese and Western Medicine, 33(3): 220–223.
Zhang H, Wu X, Xu C, 2020, Analysis of the Efficacy of Terlipressin Combined with Prostaglandin in the Treatment of Patients with Cirrhosis Complicated by Refractory Ascites by Assisting Ultrafiltration and Concentration Reflux of Ascites. Journal of Practical Liver Diseases, 23(2): 244–247.
Zhu T, Lan K, 2020, Clinical Treatment Analysis of Patients with Cirrhosis and Refractory Ascites. Jilin Medicine, 41(6): 1461–1462.
Qu X, 2020, Analysis of the Effect of Regular Ascites Discharge and Combining with Anti-Infection in the Treatment of Cirrhosis Combined with Refractory Hepatic Ascites. Journal of General Oral Medicine (Electronic Edition), 7(5): 111, 124.
Chen H, Wu Y, Liu G, 2023, Clinical Observation on 36 Cases of Patients with Cirrhosis Refractory Ascites with Blood Stasis and Water Stagnation in Patients with Umbilical Cord Penetration and Diuresis Patch Assisted Treatment. Journal of Traditional Chinese Medicine, 64(14): 1462–1468.
Hu X, Zhang L, Wang Y, et al., 2024, The Effect of Fu-Spleen, Li-Water and Drum Elimination Formula Combined with Chinese Medicine Identification and Dietary Administration on Liver Function and Nutritional Index of Ascites in Cirrhotic Liver with Viral Hepatitis B. Chinese Journal of Traditional Chinese Medicine, 42(7): 193–196.
Wang Z, Hou W, Zhang W, et al., 2022, Rifaximin Improves Clinical Symptoms and Short-Term Survival in Patients with Cirrhosis-Refractory Ascites. Chinese Journal of Liver Diseases, 30(11): 1170–1174.
Ge J, Li X, Wang Z, et al., 2022, Analysis of the Similarities and Differences in the Medication Patterns of Traditional Chinese Medicine for the Treatment of Cirrhotic Ascites and Cirrhotic Recalcitrant Ascites Based on Data Mining. Journal of Integrated Chinese and Western Medicine and Liver Disease, 32(4): 347–351.
Zhan H, Du Y, Wang S, 2022, Study on the Effect of Terlipressin Combined with Ascites Concentrating Retraction in the Treatment of Patients with Cirrhosis Complicated by Recalcitrant Ascites. Journal of Practical Liver Diseases, 25(3): 395–398.
Shi S, He D, Lin S, 2021, Effectiveness and Safety of Tolvaptan Tablets in the Treatment of Ascites and Hyponatraemia in Liver Cirrhosis. Infectious Disease Information, 34(3): 246–249.
Ma J, Liu Y, 2021, Clinical Study on the Treatment of Intractable Ascites in Liver Cirrhosis by Nourishing Yin and Inducing Diuresis Formula Together with Excretion of Ascites and Infusion of Albumin. Shaanxi Traditional Chinese Medicine, 42(1): 87–89.
Wang G, Zhu Q, Tang J, et al., 2021, Clinical Study on the Treatment of Intractable Ascites in Hepatitis B Cirrhosis by Diuresis and Dropsy Elimination Formula Combined with External Treatment of Traditional Chinese Medicine. Journal of Integrated Chinese and Western Medicine and Liver Disease, 31(7): 609–612.